FDA Gives Green Signal to Biogen’s MS Drug, Plegridy

August 16, 2014 1:38 PM

10 0

FDA Gives Green Signal to Biogen’s MS Drug, Plegridy

On Friday, the Food and Drug Administration gave green signal to Biogen Idec to market its new injectable drug meant for adults having multiple sclerosis.

The federal regulators have approved the drug called Plegridy as a longer lasting treatment for patients suffering from relapsing-remitting multiple sclerosis. The drug has been approved in the US after less than a month it was permitted by the European Commission.

Also watch: James Harden responds to Draymond Green's criticism of his 'trend-setting' play

Read more

To category page

Loading...